SCHEMBL21020573

SCHEMBL21020573

CCc1ccc(N(C)c2cccc3c2oc2c(C(C)(C)C)cccc23)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CHKA P35790 5/20 0.31
SIGMAR1 Q99720 1/20 0.31
EGFR P00533 1/20 0.31
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
PDGFRB P09619 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
KDR P35968 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31
TUBA3E Q6PEY2 1/20 0.31
TUBA1A Q71U36 1/20 0.31
TUBA1C Q9BQE3 1/20 0.31
TUBB6 Q9BUF5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21020303 0.89 HDAC6 (0.33) MEN1KMT2ACHKASIGMAR1EGFR
SCHEMBL20650395 0.86
SCHEMBL20800887 0.85 C5AR1 (0.33)
SCHEMBL21020574 0.85 PRSS1 (0.32) SIGMAR1
SCHEMBL20800842 0.85 KIF11 (0.33) MEN1KMT2ACHKASIGMAR1EGFR
SCHEMBL20800809 0.84 CES1 (0.30)
SCHEMBL21020576 0.83
SCHEMBL21021453 0.83 MEN1 (0.36) MEN1KMT2ACHKASIGMAR1EGFR
SCHEMBL21021022 0.83 EGFR (0.38) MEN1KMT2ACHKASIGMAR1EGFR
SCHEMBL20800890 0.82 DHFR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ETV6, ESR1 MEN1 565/4885KMT2A 280/4885CHKA 4611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.